Literature DB >> 11936462

Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns?

G Pittoni1, G Gallioi, M Zanello, L Gianotti, M F Boghen, S Colombo, F Broglio, C Santoro, G Davià, M G Papini, S Destefanis, F Minuto, C Miola, E Ghigo.   

Abstract

The aim of this study was to compare several parameters of GH/IGF-I axis activity in septic and trauma patients during Intensive Care Unit (ICU) stay. To this goal, 13 patients with sepsis (SEP) and 16 with trauma (TRA) were studied. Thirty-three adult subjects (AS) were studied as controls. Serum IGF-I and -II, IGFBP-1, -2 and -3, GH and GHBP levels were studied on day 1, 3, 5 and 7 after ICU admission, during comparable artificial nutrition in SEP and TRA and basally in AS. In 5 patients with SEP and 6 with TRA, the GH response to GHRH was evaluated on day 3. On ICU day 1, IGF-I and -II and IGFBP-3 in SEP were lower (p<0.05) than in TRA which, in turn, were lower (p<0.01) than in AS. IGF-I increased (p<0.05) both in SEP and TRA, but, on ICU day 7, those in SEP persisted lower than in TRA, which became similar to those in AS. IGF-II levels increased (p<0.05) in SEP only, persisting lower (p<0.05) than in TRA. On ICU day 1, GH in SEP and TRA were similar and did not vary until day 7, overlapping those in AS. The GH response to GHRH in SEP and TRA was similar and lower (p<0.01) than in AS. These findings indicate that IGF-I activity is impaired more in septic than in trauma patients. Reduced IGF-I activity probably reflects peripheral GH resistance though basal and GHRH-induced GH levels were not increased in these conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11936462     DOI: 10.1007/BF03343993

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  45 in total

1.  Response of IGF-1 to nutritional support in malnourished hospital patients: a possible indicator of short-term changes in nutritional status.

Authors:  S P Donahue; L S Phillips
Journal:  Am J Clin Nutr       Date:  1989-11       Impact factor: 7.045

Review 2.  Growth hormone-releasing peptides.

Authors:  E Ghigo; E Arvat; G Muccioli; F Camanni
Journal:  Eur J Endocrinol       Date:  1997-05       Impact factor: 6.664

Review 3.  Nutritional regulation of the insulin-like growth factors.

Authors:  J P Thissen; J M Ketelslegers; L E Underwood
Journal:  Endocr Rev       Date:  1994-02       Impact factor: 19.871

Review 4.  The rationale for the use of recombinant human growth hormone and insulin-like growth factor-I for catabolic conditions in humans.

Authors:  M W Haymond; N Mauras
Journal:  Horm Res       Date:  1996

5.  Plasma levels of insulin-like growth factor binding protein-3 in acute trauma patients.

Authors:  M Jeevanandam; N J Holaday; S R Petersen
Journal:  Metabolism       Date:  1995-09       Impact factor: 8.694

Review 6.  Physiology of growth hormone secretion and action.

Authors:  F F Casanueva
Journal:  Endocrinol Metab Clin North Am       Date:  1992-09       Impact factor: 4.741

7.  Pituitary-thyroid axis in critical illness.

Authors:  J Faber; C Kirkegaard; B Rasmussen; H Westh; M Busch-Sørensen; I W Jensen
Journal:  J Clin Endocrinol Metab       Date:  1987-08       Impact factor: 5.958

8.  Effects of recombinant human growth hormone in patients with severe sepsis.

Authors:  H J Voerman; R J van Schijndel; A B Groeneveld; H de Boer; J P Nauta; E A van der Veen; L G Thijs
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

9.  Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.

Authors:  R Ross; J Miell; E Freeman; J Jones; D Matthews; M Preece; C Buchanan
Journal:  Clin Endocrinol (Oxf)       Date:  1991-07       Impact factor: 3.478

10.  Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease.

Authors:  A C Timmins; A M Cotterill; S C Hughes; J M Holly; R J Ross; W Blum; C J Hinds
Journal:  Crit Care Med       Date:  1996-09       Impact factor: 7.598

View more
  2 in total

1.  GH/IGF-I axis in severe systemic disorders.

Authors:  P De Feo
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

2.  Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population.

Authors:  G Aimaretti; M Boschetti; G Corneli; V Gasco; D Valle; M Borsotti; A Rossi; A Barreca; L Fazzuoli; D Ferone; E Ghigo; F Minuto
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.